Grünenthal (Grünenthal PRO / CDMO)
Drug Product
Regulatory, Tech Transfer & Support Services
Company Overview
About
Grünenthal (Grünenthal PRO / CDMO) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Chile
Founded:2011
Employees:2,669
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Technology Platforms
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
5 sites worldwide
Grünenthal (Grünenthal PRO / CDMO) - Chile Facility
Chile
Site Capabilities
Formulation Development
Process Development
Scale-up
Grünenthal (Grünenthal PRO / CDMO) - Ecuador Facility
Ecuador
Site Capabilities
Formulation Development
Process Development
Scale-up
Grünenthal (Grünenthal PRO / CDMO) - Germany Facility
Germany
Site Capabilities
Formulation Development
Process Development
Scale-up
Grünenthal (Grünenthal PRO / CDMO) - Italy Facility
Italy
Site Capabilities
Formulation Development
Process Development
Scale-up
Grünenthal (Grünenthal PRO / CDMO) - Switzerland Facility
Switzerland
Site Capabilities
Formulation Development
Process Development
Scale-up
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-7JQN82KZ
Issued: 2020-11-17
Expires: 2025-11-01
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-OXUOK6HE
Issued: 2020-06-19
Expires: 2025-10-18
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-Z79SBOKO
Issued: 2020-05-11
Expires: 2025-02-03
Customer Reviews
No reviews available yet.
Company Documents
No documents available.
Loading CDMO intelligence...